0
2022
Apheresis Market

Apheresis Market

By Product (Devices, Disposable and Reagents, Software), By Method (Centrifugation, Membrane Separation, Selective Adsorption), By Procedure (Donor/Automated Apheresis, Therapeutic Apheresis), By End User (Blood Centers, Hospitals, Other End Users), By Component (Plasma (Plasmapheresis), Platelets (Plateletpheresis), Leukocytes (Leukapheresis or leukopheresis), Lymphocytes (Lymphopheresis or lymphapheresis), RBC's (Erythropheresis)): Global Opportunity Analysis and Industry Forecast, 2021-2030

✷  Report Code: A02520
May 2022 | Pages: 270
Tables: 181
Charts: 68
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.

 

Apheresis Market Research, 2031

The global apheresis market was valued at $2.4 billion in 2021, and is projected to reach $5.3 billion by 2031, growing at a CAGR of 8.3% from 2022 to 2031. Apheresis is withdrawal of blood from donor’s body, removal of one or more blood components such as platelets, white blood cells or plasma and transfusion of the remaining blood back into the donor during the process or at the end of the process. In apheresis, the whole blood from a patient or donor’s body is transformed within an instrument that is essentially designed as a centrifuge, in which the components of whole blood are separated. One of the separated portions is then withdrawn and the remaining components are re-transfused into the donor.

The apheresis market is expected to be positively impacted during the COVID-19 pandemic owing to the extensive application of plasma therapy in the treatment of COVID-19 infected patients.

Apheresis Market

The key factors that drive the apheresis market growth include increase in demand for blood components across the globe and surge in government initiatives toward blood donation. In addition, newly approved indications for apheresis treatment such as autoimmune hemolytic anemia, acute disseminated encephalomyelitis, and cardiac neonatal lupus further supplement the market growth. In October 2020, Haemoneticsis, blood management product company, received product approval from FDA (Food and Drug Administration) for NexSys PCS with persona technology, which customizes plasma collection based on an individual donor's body composition.

In addition, in October 2020, Kaneka Corporation, chemicals, food products, and medical devices company launched rheocarna, an adsorption type blood purification device that treats severe form of arteriosclerosis obliterans. Furthermore, increase in the use of plasma donation in the treatment of burnt patients, trauma patients, and patients suffering from serious disorders or major injuries contribute toward the growth of the market. Moreover, in COVID-19 plasma treatment therapy (convalescent plasma) is given to patients admitted due to COVID-19. On the contrary, advancements in the healthcare sector in emerging economies are expected to offer significant profitable apheresis market opportunity for key players.

The COVID-19 outbreak is anticipated to have a positive impact on growth of the global apheresis market. The COVID-19 pandemic stressed healthcare systems globally. Owing to the COVID-19, the coagulation parameters such as platelet count, fibrinogen, D-dimmer, prothrombin time (PT), activated partial thromboplastin time (aPTT), were found as complication in the patients who were severely infected, thus extensive application of plasma therapy treatment was given. The convalescent plasma (CP) therapy is used in patients who got infected due to COVID-19. According to the Article published in Lancet journal, between May 28, 2020, and June 15, 2021, 11558 (71%) of 16287 patients enrolled in recovery were eligible to receive convalescent plasma. CP therapy involves collection of plasma from the patient’s body who has recently recovered from infection and infusion of that collected plasma into the body of individual who is at risk.  Thus, above aforementioned factors impacted positively on the growth of the global apheresis market during pandemic.

Apheresis Market Segmentation

Apheresis market is segmented into product, method, procedure, component, end user, and region. On the basis of product, the market is classified into devices, disposable & reagents, and software. By method, it is categorized into centrifugation, membrane separation, and selective adsorption. Depending on procedure, it is divided into donor/automated apheresis and therapeutic apheresis. According to component, it is fragmented into plasma (plasmapheresis), platelets (plateletpheresis), leukocytes (leukapheresis), lymphocytes (lymph apheresis), and RBCS (erythropheresis). By end user, it is segmented into blood centers, hospitals, and others include academic institutions, research institutes (blood institutes), and biopharmaceutical manufacturers. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Segment Review
Depending on product, the disposable & reagent segment was the highest contributor to the market in 2021, and this trend is expected to continue during the forecast period, due to the extensive advancements that are taking place in the development of blood bags, tubing, and disposable kits. However, the same segment is expected to witness considerable growth during apheresis market forecast. 

Apheresis Market

By method, the centrifugation segment dominated the apheresis market size in 2021, and this trend is expected to continue during the forecast period, owing to the predominant use of centrifugation in the preparation of blood components such as packed red blood cells (PRBCs) and fresh frozen plasma (FFP) in a single-step heavy spin.However, the membrane separation segment is expected to witness considerable growth during the forecast period, as membrane filters play a pivotal role in filtration of  plasma from other cellular components to achieve specific cell separation.

Apheresis Market

By procedure, the donor/automated segment dominated the apheresis market share in 2021, and this trend is expected to continue during the forecast period, as blood centers have major share in the global apheresis market, which supplement the growth of the donor apheresis segment. Furthermore, surge in apheresis platelet donation and apheresis plasma donations have contributed to the market growth.However, the therapeutic apheresis segment is expected to witness considerable growth during the forecast period owing to rise in patient base suffering from chronic disorders, apheresis is performed for the removal of disease mediator in plasma (autologous/allogenic antibodies), removal diseased cells (sickle or parasite-infected red cells), removal of excess cells (essential thrombocythemia), and replacement with normal blood components. 

Apheresis Market

By component, the plasma (plasmapheresis) segment dominated the market in 2021, and this trend is expected to continue during the forecast period, owing to its wide utilization across renal & metabolic diseases and hematologic & neurologic disorders. However, the platelet pheresis segment is expected to witness considerable growth during the forecast period, due to soaring number of platelet apheresis procedures across the globe.

Apheresis Market
By Component

Your browser does not support the canvas element.

The plasma (plasmapheresis) segment dominated the market in 2021, and is expected to continue this trend during the forecast period.

Get more information on this report : Request Sample Pages

By end user, blood centers segment dominated the market in 2021, and this trend is expected to continue during the forecast period, as donor apheresis forms a major constituent of the apheresis industry, and maximum donor apheresis procedures are performed in the blood centers across the globe. However, the other end user segment is expected to witness considerable growth during the forecast period, as biopharmaceutical manufacturers are the major contributors to the robust growth of this segment, owing to increase in demand for plasma-based drugs.

Apheresis Market
By End User

Your browser does not support the canvas element.

The blood centers segment dominated the market in 2021, and is expected to continue this trend during the forecast period

Get more information on this report : Request Sample Pages

Region-wise, North America dominated the apheresis market size in 2021, and is expected to be dominant during the forecast period, owing to the early adoption of novel apheresis systems and increase in prevalence of blood-related disorders in this region. 
However, Asia-Pacific is expected to register highest CAGR of 9.3% from 2021 to 2031, owing to presence of high population base and surge in geriatric population (more susceptible to chronic injuries and disorders).

Apheresis Market
By Region

2031
North America 
Europe
Asia-Pacific
LAMEA

North America garnered the largest revenue share in 2021. However, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.

Get more information on this report : Request Sample Pages

The key players operating in the global Apheresis market include Asahi Kasei Corporation, B. Braun Melsungen AG, Cerus Corporation, Fresenius Kabi, Haemonetics Corporation, Charles River Laboratories International, Inc, Kaneka Corporation, Kawasumi Laboratories Inc, Nikkiso Co. Ltd, Terumo BCT.     

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the apheresis market analysis from 2022 to 2031 to identify the prevailing apheresis market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the apheresis market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global apheresis market trends, key players, market segments, application areas, and market growth strategies.

Apheresis Market Report Highlights

Aspects Details
Market Size By 2031 USD 5.3 billion
Growth Rate CAGR of 8.3%
Forecast period 2021 - 2031
Report Pages 270
By Product
  • Disposable and Reagents
  • Software
  • Devices
By Method
  • Centrifugation
  • Membrane Separation
  • Selective Adsorption
By Procedure
  • Donor/Automated Apheresis
  • Therapeutic Apheresis
By End User
  • Blood Centers
  • Hospitals
  • Other End Users
By Component
  • Plasma (Plasmapheresis)
  • Platelets (Plateletpheresis)
  • Leukocytes (Leukapheresis or leukopheresis)
  • Lymphocytes (Lymphopheresis or lymphapheresis)
  • RBC's (Erythropheresis)
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific  (Japan, China, India, Australia, South Korea, Rest of Asia-Pacific)
  • LAMEA  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Key Market Players Fresenius Kabi, Charles River Laboratories International, Inc., Cerus Corporation, Nikkiso Co., Ltd, B. Braun Melsungen AG, Kawasumi Laboratories Inc, Asahi Kasei Medical Co., Ltd, Haemonetics Corporation, Terumo BCT, Inc, Kaneka Corporation

Analyst Review

Rise in number of donor apheresis procedures have strongly contributed to the global market growth. Moreover, increase in demand for blood components globally is expected to offer profitable opportunities for the expansion of the market. In addition, therapeutic apheresis is majorly carried out among patients suffering from Good pasture syndrome, preeclampsia, and eclampsia in pregnancy, which has piqued the interest of several companies to manufacture efficient and advanced apheresis systems.
Surge in advancements of disposables associated with the apheresis procedures has largely contributed in the market revenue and is expected to maintain this trend throughout the forecast period. Single-cycle apheresis procedures consume multiple disposable parts, and such intensive consumption of disposables significantly contributes toward revenue generation. Moreover, single-use products curb the risk of infection, which is of high significance in the apheresis as well as transfusion procedures.
Increase in awareness toward blood donations and rise in government initiatives promoting blood donations drive the market growth. Upsurge in healthcare expenditure in the emerging economies is anticipated to offer lucrative opportunities for the market expansion.

 
  • CHAPTER 1: INTRODUCTION

    • 1.1. Report description

    • 1.2. Key market segments

    • 1.3. Key benefits to the stakeholders

    • 1.4. Research Methodology

      • 1.4.1. Primary research

      • 1.4.2. Secondary research

      • 1.4.3. Analyst tools and models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET OVERVIEW

    • 3.1. Market definition and scope

    • 3.2. Key findings

      • 3.2.1. Top impacting factors

      • 3.2.2. Top investment pockets

    • 3.3. Porter’s five forces analysis

      • 3.3.1. Low bargaining power of suppliers

      • 3.3.2. Low threat of new entrants

      • 3.3.3. Low threat of substitutes

      • 3.3.4. Low intensity of rivalry

      • 3.3.5. Low bargaining power of buyers

    • 3.4. Market dynamics

      • 3.4.1. Drivers

        • 3.4.1.1. Increase in demand for blood components across the globe
        • 3.4.1.2. Surge in government initiatives toward blood donation
      • 3.4.2. Restraints

        • 3.4.2.1. High Cost of Apheresis Equipment
      • 3.4.3. Opportunities

        • 3.4.3.1. Newly approved indications for apheresis treatment
  • CHAPTER 4: APHERESIS MARKET, BY PRODUCT

    • 4.1. Overview

      • 4.1.1. Market size and forecast

    • 4.2. Devices

      • 4.2.1. Key market trends, growth factors and opportunities

      • 4.2.2. Market size and forecast, by region

      • 4.2.3. Market share analysis by country

    • 4.3. Disposable and Reagents

      • 4.3.1. Key market trends, growth factors and opportunities

      • 4.3.2. Market size and forecast, by region

      • 4.3.3. Market share analysis by country

    • 4.4. Software

      • 4.4.1. Key market trends, growth factors and opportunities

      • 4.4.2. Market size and forecast, by region

      • 4.4.3. Market share analysis by country

  • CHAPTER 5: APHERESIS MARKET, BY METHOD

    • 5.1. Overview

      • 5.1.1. Market size and forecast

    • 5.2. Centrifugation

      • 5.2.1. Key market trends, growth factors and opportunities

      • 5.2.2. Market size and forecast, by region

      • 5.2.3. Market share analysis by country

    • 5.3. Membrane Separation

      • 5.3.1. Key market trends, growth factors and opportunities

      • 5.3.2. Market size and forecast, by region

      • 5.3.3. Market share analysis by country

    • 5.4. Selective Adsorption

      • 5.4.1. Key market trends, growth factors and opportunities

      • 5.4.2. Market size and forecast, by region

      • 5.4.3. Market share analysis by country

  • CHAPTER 6: APHERESIS MARKET, BY PROCEDURE

    • 6.1. Overview

      • 6.1.1. Market size and forecast

    • 6.2. Donor/Automated Apheresis

      • 6.2.1. Key market trends, growth factors and opportunities

      • 6.2.2. Market size and forecast, by region

      • 6.2.3. Market share analysis by country

    • 6.3. Therapeutic Apheresis

      • 6.3.1. Key market trends, growth factors and opportunities

      • 6.3.2. Market size and forecast, by region

      • 6.3.3. Market share analysis by country

  • CHAPTER 7: APHERESIS MARKET, BY COMPONENT

    • 7.1. Overview

      • 7.1.1. Market size and forecast

    • 7.2. Plasma (Plasmapheresis)

      • 7.2.1. Key market trends, growth factors and opportunities

      • 7.2.2. Market size and forecast, by region

      • 7.2.3. Market share analysis by country

    • 7.3. Platelets (Plateletpheresis)

      • 7.3.1. Key market trends, growth factors and opportunities

      • 7.3.2. Market size and forecast, by region

      • 7.3.3. Market share analysis by country

    • 7.4. Leukocytes (Leukapheresis or leukopheresis)

      • 7.4.1. Key market trends, growth factors and opportunities

      • 7.4.2. Market size and forecast, by region

      • 7.4.3. Market share analysis by country

    • 7.5. Lymphocytes (Lymphopheresis or lymphapheresis)

      • 7.5.1. Key market trends, growth factors and opportunities

      • 7.5.2. Market size and forecast, by region

      • 7.5.3. Market share analysis by country

    • 7.6. RBC's (Erythropheresis)

      • 7.6.1. Key market trends, growth factors and opportunities

      • 7.6.2. Market size and forecast, by region

      • 7.6.3. Market share analysis by country

  • CHAPTER 8: APHERESIS MARKET, BY END USER

    • 8.1. Overview

      • 8.1.1. Market size and forecast

    • 8.2. Blood Centers

      • 8.2.1. Key market trends, growth factors and opportunities

      • 8.2.2. Market size and forecast, by region

      • 8.2.3. Market share analysis by country

    • 8.3. Hospitals

      • 8.3.1. Key market trends, growth factors and opportunities

      • 8.3.2. Market size and forecast, by region

      • 8.3.3. Market share analysis by country

    • 8.4. Other End Users

      • 8.4.1. Key market trends, growth factors and opportunities

      • 8.4.2. Market size and forecast, by region

      • 8.4.3. Market share analysis by country

  • CHAPTER 9: APHERESIS MARKET, BY REGION

    • 9.1. Overview

      • 9.1.1. Market size and forecast By Region

    • 9.2. North America

      • 9.2.1. Key market trends, growth factors and opportunities

      • 9.2.2. Market size and forecast, by Product

      • 9.2.3. Market size and forecast, by Method

      • 9.2.4. Market size and forecast, by Procedure

      • 9.2.5. Market size and forecast, by Component

      • 9.2.6. Market size and forecast, by End User

      • 9.2.7. Market size and forecast, by country

        • 9.2.7.1. U.S.
          • 9.2.7.1.1. Market size and forecast, by Product
          • 9.2.7.1.2. Market size and forecast, by Method
          • 9.2.7.1.3. Market size and forecast, by Procedure
          • 9.2.7.1.4. Market size and forecast, by Component
          • 9.2.7.1.5. Market size and forecast, by End User
        • 9.2.7.2. Canada
          • 9.2.7.2.1. Market size and forecast, by Product
          • 9.2.7.2.2. Market size and forecast, by Method
          • 9.2.7.2.3. Market size and forecast, by Procedure
          • 9.2.7.2.4. Market size and forecast, by Component
          • 9.2.7.2.5. Market size and forecast, by End User
        • 9.2.7.3. Mexico
          • 9.2.7.3.1. Market size and forecast, by Product
          • 9.2.7.3.2. Market size and forecast, by Method
          • 9.2.7.3.3. Market size and forecast, by Procedure
          • 9.2.7.3.4. Market size and forecast, by Component
          • 9.2.7.3.5. Market size and forecast, by End User
    • 9.3. Europe

      • 9.3.1. Key market trends, growth factors and opportunities

      • 9.3.2. Market size and forecast, by Product

      • 9.3.3. Market size and forecast, by Method

      • 9.3.4. Market size and forecast, by Procedure

      • 9.3.5. Market size and forecast, by Component

      • 9.3.6. Market size and forecast, by End User

      • 9.3.7. Market size and forecast, by country

        • 9.3.7.1. Germany
          • 9.3.7.1.1. Market size and forecast, by Product
          • 9.3.7.1.2. Market size and forecast, by Method
          • 9.3.7.1.3. Market size and forecast, by Procedure
          • 9.3.7.1.4. Market size and forecast, by Component
          • 9.3.7.1.5. Market size and forecast, by End User
        • 9.3.7.2. France
          • 9.3.7.2.1. Market size and forecast, by Product
          • 9.3.7.2.2. Market size and forecast, by Method
          • 9.3.7.2.3. Market size and forecast, by Procedure
          • 9.3.7.2.4. Market size and forecast, by Component
          • 9.3.7.2.5. Market size and forecast, by End User
        • 9.3.7.3. U.K.
          • 9.3.7.3.1. Market size and forecast, by Product
          • 9.3.7.3.2. Market size and forecast, by Method
          • 9.3.7.3.3. Market size and forecast, by Procedure
          • 9.3.7.3.4. Market size and forecast, by Component
          • 9.3.7.3.5. Market size and forecast, by End User
        • 9.3.7.4. Italy
          • 9.3.7.4.1. Market size and forecast, by Product
          • 9.3.7.4.2. Market size and forecast, by Method
          • 9.3.7.4.3. Market size and forecast, by Procedure
          • 9.3.7.4.4. Market size and forecast, by Component
          • 9.3.7.4.5. Market size and forecast, by End User
        • 9.3.7.5. Spain
          • 9.3.7.5.1. Market size and forecast, by Product
          • 9.3.7.5.2. Market size and forecast, by Method
          • 9.3.7.5.3. Market size and forecast, by Procedure
          • 9.3.7.5.4. Market size and forecast, by Component
          • 9.3.7.5.5. Market size and forecast, by End User
        • 9.3.7.6. Rest of Europe
          • 9.3.7.6.1. Market size and forecast, by Product
          • 9.3.7.6.2. Market size and forecast, by Method
          • 9.3.7.6.3. Market size and forecast, by Procedure
          • 9.3.7.6.4. Market size and forecast, by Component
          • 9.3.7.6.5. Market size and forecast, by End User
    • 9.4. Asia-Pacific

      • 9.4.1. Key market trends, growth factors and opportunities

      • 9.4.2. Market size and forecast, by Product

      • 9.4.3. Market size and forecast, by Method

      • 9.4.4. Market size and forecast, by Procedure

      • 9.4.5. Market size and forecast, by Component

      • 9.4.6. Market size and forecast, by End User

      • 9.4.7. Market size and forecast, by country

        • 9.4.7.1. Japan
          • 9.4.7.1.1. Market size and forecast, by Product
          • 9.4.7.1.2. Market size and forecast, by Method
          • 9.4.7.1.3. Market size and forecast, by Procedure
          • 9.4.7.1.4. Market size and forecast, by Component
          • 9.4.7.1.5. Market size and forecast, by End User
        • 9.4.7.2. China
          • 9.4.7.2.1. Market size and forecast, by Product
          • 9.4.7.2.2. Market size and forecast, by Method
          • 9.4.7.2.3. Market size and forecast, by Procedure
          • 9.4.7.2.4. Market size and forecast, by Component
          • 9.4.7.2.5. Market size and forecast, by End User
        • 9.4.7.3. India
          • 9.4.7.3.1. Market size and forecast, by Product
          • 9.4.7.3.2. Market size and forecast, by Method
          • 9.4.7.3.3. Market size and forecast, by Procedure
          • 9.4.7.3.4. Market size and forecast, by Component
          • 9.4.7.3.5. Market size and forecast, by End User
        • 9.4.7.4. Australia
          • 9.4.7.4.1. Market size and forecast, by Product
          • 9.4.7.4.2. Market size and forecast, by Method
          • 9.4.7.4.3. Market size and forecast, by Procedure
          • 9.4.7.4.4. Market size and forecast, by Component
          • 9.4.7.4.5. Market size and forecast, by End User
        • 9.4.7.5. South Korea
          • 9.4.7.5.1. Market size and forecast, by Product
          • 9.4.7.5.2. Market size and forecast, by Method
          • 9.4.7.5.3. Market size and forecast, by Procedure
          • 9.4.7.5.4. Market size and forecast, by Component
          • 9.4.7.5.5. Market size and forecast, by End User
        • 9.4.7.6. Rest of Asia-Pacific
          • 9.4.7.6.1. Market size and forecast, by Product
          • 9.4.7.6.2. Market size and forecast, by Method
          • 9.4.7.6.3. Market size and forecast, by Procedure
          • 9.4.7.6.4. Market size and forecast, by Component
          • 9.4.7.6.5. Market size and forecast, by End User
    • 9.5. LAMEA

      • 9.5.1. Key market trends, growth factors and opportunities

      • 9.5.2. Market size and forecast, by Product

      • 9.5.3. Market size and forecast, by Method

      • 9.5.4. Market size and forecast, by Procedure

      • 9.5.5. Market size and forecast, by Component

      • 9.5.6. Market size and forecast, by End User

      • 9.5.7. Market size and forecast, by country

        • 9.5.7.1. Brazil
          • 9.5.7.1.1. Market size and forecast, by Product
          • 9.5.7.1.2. Market size and forecast, by Method
          • 9.5.7.1.3. Market size and forecast, by Procedure
          • 9.5.7.1.4. Market size and forecast, by Component
          • 9.5.7.1.5. Market size and forecast, by End User
        • 9.5.7.2. Saudi Arabia
          • 9.5.7.2.1. Market size and forecast, by Product
          • 9.5.7.2.2. Market size and forecast, by Method
          • 9.5.7.2.3. Market size and forecast, by Procedure
          • 9.5.7.2.4. Market size and forecast, by Component
          • 9.5.7.2.5. Market size and forecast, by End User
        • 9.5.7.3. South Africa
          • 9.5.7.3.1. Market size and forecast, by Product
          • 9.5.7.3.2. Market size and forecast, by Method
          • 9.5.7.3.3. Market size and forecast, by Procedure
          • 9.5.7.3.4. Market size and forecast, by Component
          • 9.5.7.3.5. Market size and forecast, by End User
        • 9.5.7.4. Rest of LAMEA
          • 9.5.7.4.1. Market size and forecast, by Product
          • 9.5.7.4.2. Market size and forecast, by Method
          • 9.5.7.4.3. Market size and forecast, by Procedure
          • 9.5.7.4.4. Market size and forecast, by Component
          • 9.5.7.4.5. Market size and forecast, by End User
  • CHAPTER 10: COMPETITIVE LANDSCAPE

    • 10.1. Introduction

    • 10.2. Top winning strategies

    • 10.3. Product Mapping of Top 10 Player

    • 10.4. Competitive Dashboard

    • 10.5. Competitive Heatmap

    • 10.6. Top player positioning, 2021

  • CHAPTER 11: COMPANY PROFILES

    • 11.1. Haemonetics Corporation

      • 11.1.1. Company overview

      • 11.1.2. Key Executives

      • 11.1.3. Company snapshot

      • 11.1.4. Operating business segments

      • 11.1.5. Product portfolio

      • 11.1.6. Business performance

    • 11.2. Fresenius Kabi

      • 11.2.1. Company overview

      • 11.2.2. Key Executives

      • 11.2.3. Company snapshot

      • 11.2.4. Operating business segments

      • 11.2.5. Product portfolio

    • 11.3. Terumo BCT, Inc

      • 11.3.1. Company overview

      • 11.3.2. Key Executives

      • 11.3.3. Company snapshot

      • 11.3.4. Operating business segments

      • 11.3.5. Product portfolio

    • 11.4. Asahi Kasei Medical Co., Ltd

      • 11.4.1. Company overview

      • 11.4.2. Key Executives

      • 11.4.3. Company snapshot

      • 11.4.4. Operating business segments

      • 11.4.5. Product portfolio

    • 11.5. Kaneka Corporation

      • 11.5.1. Company overview

      • 11.5.2. Key Executives

      • 11.5.3. Company snapshot

      • 11.5.4. Operating business segments

      • 11.5.5. Product portfolio

      • 11.5.6. Business performance

    • 11.6. Kawasumi Laboratories Inc

      • 11.6.1. Company overview

      • 11.6.2. Key Executives

      • 11.6.3. Company snapshot

      • 11.6.4. Operating business segments

      • 11.6.5. Product portfolio

    • 11.7. Cerus Corporation

      • 11.7.1. Company overview

      • 11.7.2. Key Executives

      • 11.7.3. Company snapshot

      • 11.7.4. Operating business segments

      • 11.7.5. Product portfolio

    • 11.8. B. Braun Melsungen AG

      • 11.8.1. Company overview

      • 11.8.2. Key Executives

      • 11.8.3. Company snapshot

      • 11.8.4. Operating business segments

      • 11.8.5. Product portfolio

      • 11.8.6. Business performance

    • 11.9. Nikkiso Co., Ltd

      • 11.9.1. Company overview

      • 11.9.2. Key Executives

      • 11.9.3. Company snapshot

      • 11.9.4. Operating business segments

      • 11.9.5. Product portfolio

    • 11.10. Charles River Laboratories International, Inc.

      • 11.10.1. Company overview

      • 11.10.2. Key Executives

      • 11.10.3. Company snapshot

      • 11.10.4. Operating business segments

      • 11.10.5. Product portfolio

      • 11.10.6. Business performance

  • LIST OF TABLES

  • TABLE 01. GLOBAL APHERESIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 02. APHERESIS MARKET FOR DEVICES, BY REGION, 2021-2031 ($MILLION)
    TABLE 03. APHERESIS MARKET FOR DISPOSABLE AND REAGENTS, BY REGION, 2021-2031 ($MILLION)
    TABLE 04. APHERESIS MARKET FOR SOFTWARE, BY REGION, 2021-2031 ($MILLION)
    TABLE 05. GLOBAL APHERESIS MARKET, BY METHOD, 2021-2031 ($MILLION)
    TABLE 06. APHERESIS MARKET FOR CENTRIFUGATION, BY REGION, 2021-2031 ($MILLION)
    TABLE 07. APHERESIS MARKET FOR MEMBRANE SEPARATION, BY REGION, 2021-2031 ($MILLION)
    TABLE 08. APHERESIS MARKET FOR SELECTIVE ADSORPTION, BY REGION, 2021-2031 ($MILLION)
    TABLE 09. GLOBAL APHERESIS MARKET, BY PROCEDURE, 2021-2031 ($MILLION)
    TABLE 10. APHERESIS MARKET FOR DONOR/AUTOMATED APHERESIS, BY REGION, 2021-2031 ($MILLION)
    TABLE 11. APHERESIS MARKET FOR THERAPEUTIC APHERESIS, BY REGION, 2021-2031 ($MILLION)
    TABLE 12. GLOBAL APHERESIS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
    TABLE 13. APHERESIS MARKET FOR PLASMA (PLASMAPHERESIS), BY REGION, 2021-2031 ($MILLION)
    TABLE 14. APHERESIS MARKET FOR PLATELETS (PLATELETPHERESIS), BY REGION, 2021-2031 ($MILLION)
    TABLE 15. APHERESIS MARKET FOR LEUKOCYTES (LEUKAPHERESIS OR LEUKOPHERESIS), BY REGION, 2021-2031 ($MILLION)
    TABLE 16. APHERESIS MARKET FOR LYMPHOCYTES (LYMPHOPHERESIS OR LYMPHAPHERESIS), BY REGION, 2021-2031 ($MILLION)
    TABLE 17. APHERESIS MARKET FOR RBC'S (ERYTHROPHERESIS), BY REGION, 2021-2031 ($MILLION)
    TABLE 18. GLOBAL APHERESIS MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 19. APHERESIS MARKET FOR BLOOD CENTERS, BY REGION, 2021-2031 ($MILLION)
    TABLE 20. APHERESIS MARKET FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)
    TABLE 21. APHERESIS MARKET FOR OTHER END USERS, BY REGION, 2021-2031 ($MILLION)
    TABLE 22. APHERESIS MARKET, BY REGION, 2021-2031 ($MILLION)
    TABLE 23. NORTH AMERICA APHERESIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 24. NORTH AMERICA APHERESIS MARKET, BY METHOD, 2021-2031 ($MILLION)
    TABLE 25. NORTH AMERICA APHERESIS MARKET, BY PROCEDURE, 2021-2031 ($MILLION)
    TABLE 26. NORTH AMERICA APHERESIS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
    TABLE 27. NORTH AMERICA APHERESIS MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 28. NORTH AMERICA APHERESIS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 29. U.S. APHERESIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 30. U.S. APHERESIS MARKET, BY METHOD, 2021-2031 ($MILLION)
    TABLE 31. U.S. APHERESIS MARKET, BY PROCEDURE, 2021-2031 ($MILLION)
    TABLE 32. U.S. APHERESIS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
    TABLE 33. U.S. APHERESIS MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 34. CANADA APHERESIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 35. CANADA APHERESIS MARKET, BY METHOD, 2021-2031 ($MILLION)
    TABLE 36. CANADA APHERESIS MARKET, BY PROCEDURE, 2021-2031 ($MILLION)
    TABLE 37. CANADA APHERESIS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
    TABLE 38. CANADA APHERESIS MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 39. MEXICO APHERESIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 40. MEXICO APHERESIS MARKET, BY METHOD, 2021-2031 ($MILLION)
    TABLE 41. MEXICO APHERESIS MARKET, BY PROCEDURE, 2021-2031 ($MILLION)
    TABLE 42. MEXICO APHERESIS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
    TABLE 43. MEXICO APHERESIS MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 44. EUROPE APHERESIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 45. EUROPE APHERESIS MARKET, BY METHOD, 2021-2031 ($MILLION)
    TABLE 46. EUROPE APHERESIS MARKET, BY PROCEDURE, 2021-2031 ($MILLION)
    TABLE 47. EUROPE APHERESIS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
    TABLE 48. EUROPE APHERESIS MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 49. EUROPE APHERESIS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 50. GERMANY APHERESIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 51. GERMANY APHERESIS MARKET, BY METHOD, 2021-2031 ($MILLION)
    TABLE 52. GERMANY APHERESIS MARKET, BY PROCEDURE, 2021-2031 ($MILLION)
    TABLE 53. GERMANY APHERESIS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
    TABLE 54. GERMANY APHERESIS MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 55. FRANCE APHERESIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 56. FRANCE APHERESIS MARKET, BY METHOD, 2021-2031 ($MILLION)
    TABLE 57. FRANCE APHERESIS MARKET, BY PROCEDURE, 2021-2031 ($MILLION)
    TABLE 58. FRANCE APHERESIS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
    TABLE 59. FRANCE APHERESIS MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 60. U.K. APHERESIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 61. U.K. APHERESIS MARKET, BY METHOD, 2021-2031 ($MILLION)
    TABLE 62. U.K. APHERESIS MARKET, BY PROCEDURE, 2021-2031 ($MILLION)
    TABLE 63. U.K. APHERESIS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
    TABLE 64. U.K. APHERESIS MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 65. ITALY APHERESIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 66. ITALY APHERESIS MARKET, BY METHOD, 2021-2031 ($MILLION)
    TABLE 67. ITALY APHERESIS MARKET, BY PROCEDURE, 2021-2031 ($MILLION)
    TABLE 68. ITALY APHERESIS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
    TABLE 69. ITALY APHERESIS MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 70. SPAIN APHERESIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 71. SPAIN APHERESIS MARKET, BY METHOD, 2021-2031 ($MILLION)
    TABLE 72. SPAIN APHERESIS MARKET, BY PROCEDURE, 2021-2031 ($MILLION)
    TABLE 73. SPAIN APHERESIS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
    TABLE 74. SPAIN APHERESIS MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 75. REST OF EUROPE APHERESIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 76. REST OF EUROPE APHERESIS MARKET, BY METHOD, 2021-2031 ($MILLION)
    TABLE 77. REST OF EUROPE APHERESIS MARKET, BY PROCEDURE, 2021-2031 ($MILLION)
    TABLE 78. REST OF EUROPE APHERESIS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
    TABLE 79. REST OF EUROPE APHERESIS MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 80. ASIA-PACIFIC APHERESIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 81. ASIA-PACIFIC APHERESIS MARKET, BY METHOD, 2021-2031 ($MILLION)
    TABLE 82. ASIA-PACIFIC APHERESIS MARKET, BY PROCEDURE, 2021-2031 ($MILLION)
    TABLE 83. ASIA-PACIFIC APHERESIS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
    TABLE 84. ASIA-PACIFIC APHERESIS MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 85. ASIA-PACIFIC APHERESIS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 86. JAPAN APHERESIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 87. JAPAN APHERESIS MARKET, BY METHOD, 2021-2031 ($MILLION)
    TABLE 88. JAPAN APHERESIS MARKET, BY PROCEDURE, 2021-2031 ($MILLION)
    TABLE 89. JAPAN APHERESIS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
    TABLE 90. JAPAN APHERESIS MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 91. CHINA APHERESIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 92. CHINA APHERESIS MARKET, BY METHOD, 2021-2031 ($MILLION)
    TABLE 93. CHINA APHERESIS MARKET, BY PROCEDURE, 2021-2031 ($MILLION)
    TABLE 94. CHINA APHERESIS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
    TABLE 95. CHINA APHERESIS MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 96. INDIA APHERESIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 97. INDIA APHERESIS MARKET, BY METHOD, 2021-2031 ($MILLION)
    TABLE 98. INDIA APHERESIS MARKET, BY PROCEDURE, 2021-2031 ($MILLION)
    TABLE 99. INDIA APHERESIS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
    TABLE 100. INDIA APHERESIS MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 101. AUSTRALIA APHERESIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 102. AUSTRALIA APHERESIS MARKET, BY METHOD, 2021-2031 ($MILLION)
    TABLE 103. AUSTRALIA APHERESIS MARKET, BY PROCEDURE, 2021-2031 ($MILLION)
    TABLE 104. AUSTRALIA APHERESIS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
    TABLE 105. AUSTRALIA APHERESIS MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 106. SOUTH KOREA APHERESIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 107. SOUTH KOREA APHERESIS MARKET, BY METHOD, 2021-2031 ($MILLION)
    TABLE 108. SOUTH KOREA APHERESIS MARKET, BY PROCEDURE, 2021-2031 ($MILLION)
    TABLE 109. SOUTH KOREA APHERESIS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
    TABLE 110. SOUTH KOREA APHERESIS MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 111. REST OF ASIA-PACIFIC APHERESIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 112. REST OF ASIA-PACIFIC APHERESIS MARKET, BY METHOD, 2021-2031 ($MILLION)
    TABLE 113. REST OF ASIA-PACIFIC APHERESIS MARKET, BY PROCEDURE, 2021-2031 ($MILLION)
    TABLE 114. REST OF ASIA-PACIFIC APHERESIS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
    TABLE 115. REST OF ASIA-PACIFIC APHERESIS MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 116. LAMEA APHERESIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 117. LAMEA APHERESIS MARKET, BY METHOD, 2021-2031 ($MILLION)
    TABLE 118. LAMEA APHERESIS MARKET, BY PROCEDURE, 2021-2031 ($MILLION)
    TABLE 119. LAMEA APHERESIS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
    TABLE 120. LAMEA APHERESIS MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 121. LAMEA APHERESIS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 122. BRAZIL APHERESIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 123. BRAZIL APHERESIS MARKET, BY METHOD, 2021-2031 ($MILLION)
    TABLE 124. BRAZIL APHERESIS MARKET, BY PROCEDURE, 2021-2031 ($MILLION)
    TABLE 125. BRAZIL APHERESIS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
    TABLE 126. BRAZIL APHERESIS MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 127. SAUDI ARABIA APHERESIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 128. SAUDI ARABIA APHERESIS MARKET, BY METHOD, 2021-2031 ($MILLION)
    TABLE 129. SAUDI ARABIA APHERESIS MARKET, BY PROCEDURE, 2021-2031 ($MILLION)
    TABLE 130. SAUDI ARABIA APHERESIS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
    TABLE 131. SAUDI ARABIA APHERESIS MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 132. SOUTH AFRICA APHERESIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 133. SOUTH AFRICA APHERESIS MARKET, BY METHOD, 2021-2031 ($MILLION)
    TABLE 134. SOUTH AFRICA APHERESIS MARKET, BY PROCEDURE, 2021-2031 ($MILLION)
    TABLE 135. SOUTH AFRICA APHERESIS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
    TABLE 136. SOUTH AFRICA APHERESIS MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 137. REST OF LAMEA APHERESIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 138. REST OF LAMEA APHERESIS MARKET, BY METHOD, 2021-2031 ($MILLION)
    TABLE 139. REST OF LAMEA APHERESIS MARKET, BY PROCEDURE, 2021-2031 ($MILLION)
    TABLE 140. REST OF LAMEA APHERESIS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
    TABLE 141. REST OF LAMEA APHERESIS MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 142. HAEMONETICS CORPORATION: KEY EXECUTIVES
    TABLE 143. HAEMONETICS CORPORATION: COMPANY SNAPSHOT
    TABLE 144. HAEMONETICS CORPORATION: PRODUCT SEGMENTS
    TABLE 145. HAEMONETICS CORPORATION: PRODUCT PORTFOLIO
    TABLE 146. FRESENIUS KABI: KEY EXECUTIVES
    TABLE 147. FRESENIUS KABI: COMPANY SNAPSHOT
    TABLE 148. FRESENIUS KABI: PRODUCT SEGMENTS
    TABLE 149. FRESENIUS KABI: PRODUCT PORTFOLIO
    TABLE 150. TERUMO BCT, INC: KEY EXECUTIVES
    TABLE 151. TERUMO BCT, INC: COMPANY SNAPSHOT
    TABLE 152. TERUMO BCT, INC: PRODUCT SEGMENTS
    TABLE 153. TERUMO BCT, INC: PRODUCT PORTFOLIO
    TABLE 154. ASAHI KASEI MEDICAL CO., LTD: KEY EXECUTIVES
    TABLE 155. ASAHI KASEI MEDICAL CO., LTD: COMPANY SNAPSHOT
    TABLE 156. ASAHI KASEI MEDICAL CO., LTD: PRODUCT SEGMENTS
    TABLE 157. ASAHI KASEI MEDICAL CO., LTD: PRODUCT PORTFOLIO
    TABLE 158. KANEKA CORPORATION: KEY EXECUTIVES
    TABLE 159. KANEKA CORPORATION: COMPANY SNAPSHOT
    TABLE 160. KANEKA CORPORATION: PRODUCT SEGMENTS
    TABLE 161. KANEKA CORPORATION: PRODUCT PORTFOLIO
    TABLE 162. KAWASUMI LABORATORIES INC: KEY EXECUTIVES
    TABLE 163. KAWASUMI LABORATORIES INC: COMPANY SNAPSHOT
    TABLE 164. KAWASUMI LABORATORIES INC: PRODUCT SEGMENTS
    TABLE 165. KAWASUMI LABORATORIES INC: PRODUCT PORTFOLIO
    TABLE 166. CERUS CORPORATION: KEY EXECUTIVES
    TABLE 167. CERUS CORPORATION: COMPANY SNAPSHOT
    TABLE 168. CERUS CORPORATION: PRODUCT SEGMENTS
    TABLE 169. CERUS CORPORATION: PRODUCT PORTFOLIO
    TABLE 170. B. BRAUN MELSUNGEN AG: KEY EXECUTIVES
    TABLE 171. B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
    TABLE 172. B. BRAUN MELSUNGEN AG: PRODUCT SEGMENTS
    TABLE 173. B. BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO
    TABLE 174. NIKKISO CO., LTD: KEY EXECUTIVES
    TABLE 175. NIKKISO CO., LTD: COMPANY SNAPSHOT
    TABLE 176. NIKKISO CO., LTD: PRODUCT SEGMENTS
    TABLE 177. NIKKISO CO., LTD: PRODUCT PORTFOLIO
    TABLE 178. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: KEY EXECUTIVES
    TABLE 179. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: COMPANY SNAPSHOT
    TABLE 180. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: SERVICE SEGMENTS
    TABLE 181. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: PRODUCT PORTFOLIO
  • LIST OF FIGURES

  • FIGURE 1.APHERESIS MARKET SEGMENTATION
    FIGURE 2.APHERESIS MARKET,2021-2031
    FIGURE 3.APHERESIS MARKET,2021-2031
    FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
    FIGURE 5.PORTER FIVE-1
    FIGURE 6.PORTER FIVE-2
    FIGURE 7.PORTER FIVE-3
    FIGURE 8.PORTER FIVE-4
    FIGURE 9.PORTER FIVE-5
    FIGURE 10.TOP PLAYER POSITIONING
    FIGURE 11.APHERESIS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
    FIGURE 12.APHERESIS MARKET,BY BY PRODUCT,2021(%)
    FIGURE 13.COMPARATIVE SHARE ANALYSIS OF DEVICES APHERESIS MARKET,2021-2031(%)
    FIGURE 14.COMPARATIVE SHARE ANALYSIS OF DISPOSABLE AND REAGENTS APHERESIS MARKET,2021-2031(%)
    FIGURE 15.COMPARATIVE SHARE ANALYSIS OF SOFTWARE APHERESIS MARKET,2021-2031(%)
    FIGURE 16.APHERESIS MARKET,BY BY METHOD,2021(%)
    FIGURE 17.COMPARATIVE SHARE ANALYSIS OF CENTRIFUGATION APHERESIS MARKET,2021-2031(%)
    FIGURE 18.COMPARATIVE SHARE ANALYSIS OF MEMBRANE SEPARATION APHERESIS MARKET,2021-2031(%)
    FIGURE 19.COMPARATIVE SHARE ANALYSIS OF SELECTIVE ADSORPTION APHERESIS MARKET,2021-2031(%)
    FIGURE 20.APHERESIS MARKET,BY BY PROCEDURE,2021(%)
    FIGURE 21.COMPARATIVE SHARE ANALYSIS OF DONOR/AUTOMATED APHERESIS APHERESIS MARKET,2021-2031(%)
    FIGURE 22.COMPARATIVE SHARE ANALYSIS OF THERAPEUTIC APHERESIS APHERESIS MARKET,2021-2031(%)
    FIGURE 23.APHERESIS MARKET,BY COMPONENT,2021(%)
    FIGURE 24.COMPARATIVE SHARE ANALYSIS OF PLASMA (PLASMAPHERESIS) APHERESIS MARKET,2021-2031(%)
    FIGURE 25.COMPARATIVE SHARE ANALYSIS OF PLATELETS (PLATELETPHERESIS) APHERESIS MARKET,2021-2031(%)
    FIGURE 26.COMPARATIVE SHARE ANALYSIS OF LEUKOCYTES (LEUKAPHERESIS OR LEUKOPHERESIS) APHERESIS MARKET,2021-2031(%)
    FIGURE 27.COMPARATIVE SHARE ANALYSIS OF LYMPHOCYTES (LYMPHOPHERESIS OR LYMPHAPHERESIS) APHERESIS MARKET,2021-2031(%)
    FIGURE 28.COMPARATIVE SHARE ANALYSIS OF RBC'S (ERYTHROPHERESIS) APHERESIS MARKET,2021-2031(%)
    FIGURE 29.APHERESIS MARKET,BY END USER,2021(%)
    FIGURE 30.COMPARATIVE SHARE ANALYSIS OF BLOOD CENTERS APHERESIS MARKET,2021-2031(%)
    FIGURE 31.COMPARATIVE SHARE ANALYSIS OF HOSPITALS APHERESIS MARKET,2021-2031(%)
    FIGURE 32.COMPARATIVE SHARE ANALYSIS OF OTHER END USERS APHERESIS MARKET,2021-2031(%)
    FIGURE 33.APHERESIS MARKET BY REGION,2021
    FIGURE 34.U.S. APHERESIS MARKET,2021-2031($MILLION)
    FIGURE 35.CANADA APHERESIS MARKET,2021-2031($MILLION)
    FIGURE 36.MEXICO APHERESIS MARKET,2021-2031($MILLION)
    FIGURE 37.GERMANY APHERESIS MARKET,2021-2031($MILLION)
    FIGURE 38.FRANCE APHERESIS MARKET,2021-2031($MILLION)
    FIGURE 39.U.K. APHERESIS MARKET,2021-2031($MILLION)
    FIGURE 40.ITALY APHERESIS MARKET,2021-2031($MILLION)
    FIGURE 41.SPAIN APHERESIS MARKET,2021-2031($MILLION)
    FIGURE 42.REST OF EUROPE APHERESIS MARKET,2021-2031($MILLION)
    FIGURE 43.JAPAN APHERESIS MARKET,2021-2031($MILLION)
    FIGURE 44.CHINA APHERESIS MARKET,2021-2031($MILLION)
    FIGURE 45.INDIA APHERESIS MARKET,2021-2031($MILLION)
    FIGURE 46.AUSTRALIA APHERESIS MARKET,2021-2031($MILLION)
    FIGURE 47.SOUTH KOREA APHERESIS MARKET,2021-2031($MILLION)
    FIGURE 48.REST OF ASIA-PACIFIC APHERESIS MARKET,2021-2031($MILLION)
    FIGURE 49.BRAZIL APHERESIS MARKET,2021-2031($MILLION)
    FIGURE 50.SAUDI ARABIA APHERESIS MARKET,2021-2031($MILLION)
    FIGURE 51.SOUTH AFRICA APHERESIS MARKET,2021-2031($MILLION)
    FIGURE 52.REST OF LAMEA APHERESIS MARKET,2021-2031($MILLION)
    FIGURE 53. TOP WINNING STRATEGIES, BY YEAR
    FIGURE 54. TOP WINNING STRATEGIES, BY DEVELOPMENT
    FIGURE 55. TOP WINNING STRATEGIES, BY COMPANY
    FIGURE 56.PRODUCT MAPPING OF TOP 10 PLAYERS
    FIGURE 57.COMPETITIVE DASHBOARD
    FIGURE 58.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
    FIGURE 59.HAEMONETICS CORPORATION.: NET SALES ,($MILLION)
    FIGURE 60.FRESENIUS KABI.: NET SALES ,($MILLION)
    FIGURE 61.TERUMO BCT, INC.: NET SALES ,($MILLION)
    FIGURE 62.ASAHI KASEI MEDICAL CO., LTD.: NET SALES ,($MILLION)
    FIGURE 63.KANEKA CORPORATION.: NET SALES ,($MILLION)
    FIGURE 64.KAWASUMI LABORATORIES INC.: NET SALES ,($MILLION)
    FIGURE 65.CERUS CORPORATION.: NET SALES ,($MILLION)
    FIGURE 66.B. BRAUN MELSUNGEN AG.: NET SALES ,($MILLION)
    FIGURE 67.NIKKISO CO., LTD.: NET SALES ,($MILLION)
    FIGURE 68.CHARLES RIVER LABORATORIES INTERNATIONAL, INC..: NET SALES ,($MILLION)

 
 

Apheresis involves processing of the whole blood so as to obtain one or more desired blood components. Increase in number of donor apheresis procedures have strongly contributed to the global market growth. Moreover, increase in demand for blood components globally is expected to offer profitable opportunities for the expansion of the market. In addition, therapeutic apheresis is largely carried out among patients suffering from Goodpasture syndrome, preeclampsia, and eclampsia in pregnancy. This has piqued the interest of several companies to manufacture efficient and advanced apheresis systems.

Increase in advancements of the disposables associated with the apheresis procedures has largely contributed in the market revenue in 2016, and is expected to maintain this trend throughout the forecast period. Single-cycle apheresis procedures consume multiple disposable parts, and such intensive consumption of disposables significantly contributes towards the revenue generation. Moreover, single-use products curb the risk of infection, which is of high significance in the apheresis as well as transfusion procedures.

Furthermore, increase in awareness towards blood donations and government initiatives promoting blood donations drive the market growth. Upsurge in healthcare expenditure in the emerging economies is anticipated to offer lucrative opportunities for the market growth.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com
 
FREQUENTLY ASKED QUESTIONS?

A. Apheresis procedures involve separation of desired components from the blood, while the remaining is either returned to the donor or the patient.

A. The total market value of apheresis market is $2,383.41 million in 2021.

A. The forecast period for apheresis market is 2022 to 2031

A. The market value of apheresis market in 2030 is $5,300.57 million.

A. The base year is 2021 in apheresis market.

A. Top companies such as, Asahi Kasei Corporation, B. Braun Melsungen AG, Cerus Corporation, Fresenius Kabi, Haemonetics Corporation held a high market position in 2021.

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Sample
RELATED TAGS

Purchase Full Report of
Apheresis Market

Start reading instantly.
This Report and over 67,404+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,570
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
    (May 2023 - May 2024)
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (May 2023 - May 2024)
  • Single User
  • $5,730
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (May 2023 - May 2024)
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (May 2023 - May 2024)
  • Enterprise
    License/PDF

  • $9,600
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (May 2023 - May 2024)
  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers